Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders

Type
01A - Journal article
Editors
Editor (Corporation)
Supervisor
Parent work
Spanish Journal of Psychiatry and Mental Health
Special issue
DOI of the original publication
Link
Series
Series number
Volume
Issue / Number
Pages / Duration
Patent number
Publisher / Publishing institution
Elsevier
Place of publication / Event location
Barcelona
Edition
Version
Programming language
Assignee
Practice partner / Client
Abstract
Introduction Clinical high risk for psychosis (CHR) states are associated with an increased risk of transition to psychosis. However, the predictive value of CHR screening interviews is dependent on pretest risk enrichment in referred patients. This poses a major obstacle to CHR outreach campaigns since they invariably lead to risk dilution through enhanced awareness. A potential compensatory strategy is to use estimates of individual pretest risk as a ‘gatekeeper’ for specialized assessment. We aimed to test a risk stratification model previously developed in London, UK (OASIS) and to train a new predictive model for the Swiss population. Method The sample was composed of 513 individuals referred for CHR assessment from six Swiss early psychosis detection services. Sociodemographic variables available at referral were used as predictors whereas the outcome variable was transition to psychosis. Results Replication of the risk stratification model developed in OASIS resulted in poor performance (Harrel's c = 0.51). Retraining resulted in moderate discrimination (Harrel's c = 0.67) which significantly differentiated between different risk groups. The lowest risk group had a cumulative transition incidence of 6.4% (CI: 0–23.1%) over two years. Conclusion Failure to replicate the OASIS risk stratification model might reflect differences in the public health care systems and referral structures between Switzerland and London. Retraining resulted in a model with adequate discrimination performance. The developed model in combination with CHR assessment result, might be useful for identifying individuals with high pretest risk, who might benefit most from specialized intervention.
Keywords
Subject (DDC)
Project
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
2950-2861
2950-2853
Language
English
Created during FHNW affiliation
Yes
Strategic action fields FHNW
Publication status
Published
Review
Expert editing/editorial review
Open access category
Hybrid
License
'https://creativecommons.org/licenses/by/4.0/'
Citation
Sprüngli-Toffel, E., Studerus, E., Curtis, L., Conchon, C., Alameda, L., Bailey, B., Caron, C., Haase, C., Gros, J., Herbrecht, E., Huber, C. G., Riecher-Rössler, A., Conus, P., Solida, A., Armando, M., Kapsaridi, A., Ducommun, M. M., Klauser, P., Plessen, K. J., et al. (2024). Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders. Spanish Journal of Psychiatry and Mental Health. https://doi.org/10.1016/j.sjpmh.2024.09.001